Nevrofibromatose type 1
Nevrofibromatose type 1 er en medfødt sykdom som kan påvirke en rekke organer. Symptomene varierer derfor mye fra person til person. De fleste tegn på sykdommen viser seg allerede i barnealderen.
Sist revidert:
Del pasientinformasjon
Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon
https://nhi.no/sykdommer/hjernenervesystem/arvelige-og-medfodte-tilstander/nevrofibromatose-type-1/Hva er nevrofibromatose type 1(NF-1)?
Symptomer
Diagnosen
Behandling
Prognose
Vil du vite mer?
Kilder
Referanser
Dette dokumentet er basert på det profesjonelle dokumentet Nevrofibromatose type 1. Referanselisten for dette dokumentet vises nedenfor.
- Theos A, Korf BR. Pathophysiology of Neurofibromatosis Type 1. Ann Intern Med 2006; 144: 842-49. Annals of Internal Medicine
- Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans DG, et al. Neurofibromatosis Type 1 and Autism Spectrum Disorder. Pediatrics 2013; 132: 1642-8. Pediatrics
- Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005; 141: 71-4. pmid:15655144 PubMed
- Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45(5):575-8. PubMed
- Garg S, Green J, Leadbitter K, et al. Neurofibromatsis Type 1 and autism spectrum disorder. Pediatrics 2013; 132: 1642-8. doi:10.1542/peds.2013-1868 DOI
- Kjærulff O, Wandall H. Sygdomsmekanismer og terapeutiske perspektiver ved neurofibromatose 1. Ugeskr Læger 2012; 174: 642. Ugeskrift for Læger
- Hamed Al-Farsi FA, Said Al-Alyani OB, Al-Kumzari A, Al-Saadi T. Systemic review and meta-analysis of the intellectual integrity of children with Neurofibromatosis type 1 (NF-1). World Neurosurg. 2021 Oct 11:S1878-8750(21)01578-3. PMID: 34648986. PubMed
- Krab LC, de Goede-Bolder A, Aarsen FK et al. Effect of Simvastatin on Cognitive Functioning in Children With Neurofibromatosis Type 1: A Randomized Controlled Trial . JAMA 2008; 300: 287-94. PubMed
- Listernick R, Ferner RE, Liu GT, Gutmann DH. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007; 61: 189-98. pmid:17387725 PubMed
- Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. . Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol 2020. pmid:31396668 PubMed